Skip to main content

Table 4 Antithrombotic agents used in the CAA population before and after CAA diagnosis

From: Prescribing patterns of coronary artery aneurysm in Taiwan

 

Before index date

After index date

1 year

3 month

6 month

1 year

N (%)

N (%)

N (%)

N (%)

Pediatric population (N = 586)

 Aspirin

182 (31.1)

479 (81.7)

482 (82.3)

486 (82.9)

 Clopidogrel

1 (0.2)

4 (0.7)

4 (0.7)

4 (0.7)

 Dipyridamole

43 (7.3)

95 (16.2)

97 (16.6)

99 (16.9)

 Warfarin

7 (1.2)

25 (4.3)

26 (4.4)

27 (4.6)

 Heparin

5 (0.9)

31 (5.3)

33 (5.6)

34 (5.8)

Adult population (N = 811)

 Aspirin

575 (70.9)

667 (82.2)

678 (83.6)

689 (85.0)

 Clopidogrel

256 (31.6)

510 (62.9)

514 (63.4)

523 (64.5)

 Dipyridamole

127 (15.7)

81 (10.0)

94 (11.6)

108 (13.3)

 Ticlopidine

32 (3.9)

26 (3.2)

31 (3.8)

36 (4.4)

 Tirofiban

22 (2.7)

28 (3.5)

28 (3.5)

29 (3.6)

 Cilostazol

20 (2.5)

26 (3.2)

29 (3.6)

41 (5.1)

 Warfarin

60 (7.4)

126 (15.5)

132 (16.3)

141 (17.4)

 Heparin

164 (20.2)

551 (67.9)

562 (69.3)

577 (71.1)

 Enoxaparin

60 (7.4)

131 (16.2)

140 (17.3)

147 (18.1)